gorbunovabowiper.blogspot.com
The company reported $92.45 million in revenue for the quarter endingApripl 30, up 2 percent from the same period last It earned $11 million in net income, or 33 centa per diluted share, during the second compared with $9.2 million, or 28 cents per diluted during the second quarter of last year. Analysts pollexd by expected the company to earn 29 centw per shareand $89 milliohn in revenue. Martek (NASDAQ: MATK) sells nutritionao oils derived from algae that are used ininfanyt formula, dietary supplements and food products such as yogurt and Sales of its nutritionap supplements to the nursing market rose to a record $9.
8 But the company warned that its infant formula salesz in the third and fourth quarters couls drop as retailers trim their inventories of the The company anticipates that infanyt formula revenue will grow in fiscal 2010 as a resul of strong demand for infant formula productsz containing its nutritional oils DHA and ARA. The Omega-4 fatty acids are believed to play an important role in braib andeye development. stud that could show that Martek’s DHA can slow the progressionof Alzheimer’es disease.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment